Understanding how many hours a student may accumulate while still in school hinges on a set limit for experiential activities. In Montana, a student pharmacist may accumulate up to one thousand five hundred hours in approved experiences—such as IPPE, APPE, or demonstration projects—while enrolled in approved courses. These hours must be earned under the supervision of a licensed pharmacist and in settings approved by the board, and they count toward internship requirements for licensure. The cap ensures a balance between classroom learning and hands-on practice, so students gain essential experience without compromising their coursework. Hours within this limit are permissible concurrently with school; hours beyond it aren’t.

Documenting allergies is essential because it directly guides safe prescribing and care decisions. Allergies are a standard part of the medical history and are routinely checked whenever a medication is ordered, helping to prevent adverse reactions or life‑threatening events. In most medical records, you’ll find a clearly recorded list of drug, food, and environmental allergies tied to the patient’s profile, and this information is actively used during medication reconciliation and decision support. Employment status isn’t typically a core piece of the clinical record; it’s more about social history and may not influence most treatment decisions. A Social Security number is sensitive information and, for privacy reasons, isn’t routinely stored in everyday medical charts. Medical imaging results are indeed documented and linked to the patient’s record, but the everyday, universally emphasized item used to safeguard pharmacotherapy and overall care is the allergy information.

The Zero Report is part of regulatory inventory documentation, so it must be kept in two places: on file with the Board of Pharmacy and at the pharmacy itself. Having a copy with the board provides an official record for regulatory review, while keeping a copy at the pharmacy ensures the report is readily available for inspections and internal reference. Storing it only in tax records or only in patient records wouldn’t meet the regulatory requirements, and restricting it to a safe isn’t the formal retention rule. The required setup is to maintain both copies.

When a narcotic drug is combined with non-narcotic active ingredients in amounts that are recognized as therapeutic, the product’s schedule is determined by how much narcotic is present per unit and per volume. In this case, ethylmorphine up to 300 mg per 100 mL or 15 mg per dosage unit, together with active non-narcotic ingredients in recognized therapeutic amounts, fits the criteria for Schedule III. The non-narcotic components and the limited narcotic content reduce the overall abuse potential compared with higher schedules, so the product is placed in Schedule III. If the narcotic amount were higher or the product lacked qualifying non-narcotic ingredients, it would be classified higher, such as Schedule II.